Literature DB >> 11770984

Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination.

W D Wilson1, J E Mihalyi, S Hussey, D P Lunn.   

Abstract

Influenza and tetanus-specific antibodies of the IgG sub-isotypes are posively transferred to foals via colostrum and inhibit their response to inactivated influenza vaccines and tetanus toxoid. High titres of influenza antibodies of IgGa and IgGb subisotypes and tetanus antibodies of the IgGa, IgGb and IgG(T) subisotypes were detected in postsucking serum samples collected from foals born to mares that had received booster doses of multicomponent vaccines during the last 2 months of gestation. Thereafter, titres declined in an exponential manner but were still detectable in all foals at age 26 weeks, regardless of whether they had been vaccinated prior to age 26 weeks. Mean +/- s.e. half-life of decline of influenza IgGa antibodies (27.0 +/- 2.3 days) was significantly shorter than that of influenza IgGb antibodies (39.1 +/- 2.7 days; P<0.005). Tetanus IgGa and IgGb antibodies declined with half-lives of 28.8 +/- 3.0 and 34.8 +/- 5.1 days, respectively. Titres of tetanus IgG(T) antibodies were substantially higher than those of influenza IgG(T) antibodies in postsucking samples and remained so through age 26 weeks, declining with a half-life of approximately 35 days. Postsucking titres of tetanus and influenza antibodies of the IgA isotype were low and declined rapidly to undetectable levels. Yearlings showed significant increases in titre of influenza IgGa, IgGb and IgG(T) subisotype antibodies but no increase in influenza IgA antibodies in response to 2 doses of multicomponent vaccines containing tetanus toxoid and inactivated influenza A-1 and A-2 antigens. Yearlings also showed strong tetanus IgGa, IgGb and IgG(T) subisotype responses to one dose of vaccine and a substantial further rise in titre in response to administration of a second dose 3 weeks later, but failed to show an increase in titre of tetanus IgA antibodies. The influenza and tetanus IgGa, IgGb and IgG(T) subisotype responses of 6-month-old foals to vaccination followed the same pattern as those shown by yearlings but titres were generally lower. In contrast, 3-month-old foals failed to show increases in titre of either influenza or tetanus IgG subisotypes in response to 2 doses of vaccine and generally needed 1-3 additional booster doses of vaccine to achieve titres similar to those achieved by yearlings after 2 doses. Based on the finding that maternal antibodies exert a significant inhibitory effect on the response of foals to tetanus toxoid and inactivated influenza antigens, it is recommended that primary immunisation of foals born to vaccinated mares should not commence before age 6 months.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11770984     DOI: 10.2746/042516401776249435

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  11 in total

1.  Equine neonates have attenuated humoral and cell-mediated immune responses to a killed adjuvanted vaccine compared to adult horses.

Authors:  Clare Ryan; Steeve Giguère
Journal:  Clin Vaccine Immunol       Date:  2010-10-13

2.  Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential.

Authors:  O Nicolas Schwint; Massaro W Ueti; Guy H Palmer; Lowell S Kappmeyer; Melissa T Hines; R Timothy Cordes; Donald P Knowles; Glen A Scoles
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

3.  Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses.

Authors:  T M Chambers; M Quinlivan; T Sturgill; A Cullinane; D W Horohov; D Zamarin; S Arkins; A García-Sastre; P Palese
Journal:  Equine Vet J       Date:  2009-01       Impact factor: 2.888

4.  A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus.

Authors:  Sarah Gildea; Sean Arkins; Ann Cullinane
Journal:  Influenza Other Respir Viruses       Date:  2010-11       Impact factor: 4.380

5.  Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate.

Authors:  Rebecca L Tallmadge; Steven C Miller; Stephen A Parry; Maria Julia B Felippe
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

6.  Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody.

Authors:  Jianjun Chen; Fenghua Zhang; Fang Fang; Haiyan Chang; Ze Chen
Journal:  BMC Infect Dis       Date:  2007-10-16       Impact factor: 3.090

Review 7.  Passive immunisation, an old idea revisited: Basic principles and application to modern animal production systems.

Authors:  Chris J Hedegaard; Peter M H Heegaard
Journal:  Vet Immunol Immunopathol       Date:  2016-04-26       Impact factor: 2.046

Review 8.  Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy.

Authors:  Judy A Beeler; Maryna C Eichelberger
Journal:  Microb Pathog       Date:  2012-12-13       Impact factor: 3.738

9.  Investigations on the occurrence of tapeworm infections in German horse populations with comparison of different antibody detection methods based on saliva and serum samples.

Authors:  Laura Jürgenschellert; Jürgen Krücken; Corrine J Austin; Kirsty L Lightbody; Eric Bousquet; Georg von Samson-Himmelstjerna
Journal:  Parasit Vectors       Date:  2020-09-10       Impact factor: 3.876

Review 10.  Equids' Core Vaccines Guidelines in North America: Considerations and Prospective.

Authors:  Hélène Desanti-Consoli; Juliette Bouillon; Ronan J J Chapuis
Journal:  Vaccines (Basel)       Date:  2022-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.